MAPK15 and ovarian carcinoma: The low-expression groups comprised a higher ratio of elderly patients, poorly differentiated tumors, and advanced stage (Figure 2C–E), suggesting that MAPK15 expression is involved in the carcinogenesis and progression of ovarian cancer.